Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01574157 · ClinicalTrials.gov registry record · NA

Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.

A NA study of Diabetes Mellitus and Chronic Renal Insufficiency, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
74
Enrollment target
1
Study location

NCT01574157 is a NA study of Diabetes Mellitus and Chronic Renal Insufficiency that has completed, run by VA Office of Research and Development. The registered enrollment target is 74 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01574157, a NA study of Diabetes Mellitus and Chronic Renal Insufficiency, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
74 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see if treatment with sodium bicarbonate will lower urine levels of proteins that are indicators of kidney damage in people with diabetes who also have chronic kidney disease.

Interventions

  • DRUG Placebo
  • DRUG Sodium bicarbonate

Study Locations (1)

Utah

  • VA Salt Lake City Health Care System, Salt Lake City, UT - Salt Lake City

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2012-11-05
Est. Completion 2018-05-01
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT01574157

The ClinicalTrials.gov registry entry for NCT01574157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (96% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01574157 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT01574157 about?

NCT01574157 is a clinical study titled "Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.". The purpose of this study is to see if treatment with sodium bicarbonate will lower urine levels of proteins that are indicators of kidney damage in people with diabetes who also have chronic kidney disease.

What is the current status of trial NCT01574157?

This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2012-11-05. Estimated completion is 2018-05-01.

What conditions does trial NCT01574157 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Chronic Renal Insufficiency.

What interventions are being tested in trial NCT01574157?

The interventions under investigation include: Placebo (DRUG), Sodium bicarbonate (DRUG).

Who is sponsoring clinical trial NCT01574157?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01574157 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.